Overview

Rio Trial - ReoPro and Peripheral Arterial Intervention to Improve Clinical Outcome in Patients With Peripheral Arterial Disease

Status:
Unknown status

Trial end date:
2009-12-01

Target enrollment:

Participant gender:

Summary

The Rio Study is a randomized, double blinded German- Swiss- Austria multi-centre trial on the efficacy and safety of ReoPro together with interventional recanalization of TASC D lesions in the SFA and popliteal artery.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

University Hospital Tuebingen

Collaborator:

University of Bern

Treatments:

Abciximab